Mesalamine

Last Updated: 02/24/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5429 publications

When Textbook Meets Reality: A Rare Case of Boerhaave's Syndrome With Mackler's Triad.

When Textbook Meets Reality: A Rare Case of Boerhaave's Syndrome With Mackler's Triad.

Journal: Journal of investigative medicine high impact case reports

Published: January 23, 2026

Comparison of Surgery and Medicine on the Impact of Diverticulitis (COSMID) trial: a protocol for a pragmatic randomised study of diverticulitis treatment in the USA.

Comparison of Surgery and Medicine on the Impact of Diverticulitis (COSMID) trial: a protocol for a pragmatic randomised study of diverticulitis treatment in the USA.

Journal: BMJ open

Published: January 08, 2026

An oral-to-urinalysis fluorescent prodrug platform for IBD theranostics.

An oral-to-urinalysis fluorescent prodrug platform for IBD theranostics.

Journal: Biomaterials

Published: January 01, 2026

Severe Hypercholesterolemia Caused by Mesalazine Which Is a Key Drug of Ulcerative Colitis: A Case Report.

Severe Hypercholesterolemia Caused by Mesalazine Which Is a Key Drug of Ulcerative Colitis: A Case Report.

Journal: Internal medicine (Tokyo, Japan)

Published: December 24, 2025

5-Aminosalicylic Acid-Induced Colitis in a Patient with Rheumatoid Arthritis Without Inflammatory Bowel Disease: A Case Report.

5-Aminosalicylic Acid-Induced Colitis in a Patient with Rheumatoid Arthritis Without Inflammatory Bowel Disease: A Case Report.

Journal: Internal medicine (Tokyo, Japan)

Published: December 24, 2025

Efficacy of 5-Aminosalicylic Acid Continuation versus Discontinuation in Patients with Ulcerative Colitis Escalated to Advanced Therapy: A Systematic Review and Meta-Analysis of Adjusted Effect Estimates.

Efficacy of 5-Aminosalicylic Acid Continuation versus Discontinuation in Patients with Ulcerative Colitis Escalated to Advanced Therapy: A Systematic Review and Meta-Analysis of Adjusted Effect Estimates.

Journal: Journal of Crohn's & colitis

Published: December 02, 2025

Efficacy of 5-aminosalicylic acid continuation versus discontinuation in patients with ulcerative colitis escalated to advanced therapy: a systematic review and meta-analysis of adjusted effect estimates.

Efficacy of 5-aminosalicylic acid continuation versus discontinuation in patients with ulcerative colitis escalated to advanced therapy: a systematic review and meta-analysis of adjusted effect estimates.

Journal: Journal of Crohn's & colitis

Published: December 02, 2025

Addition of pulse corticosteroids to oral prednisone in moderately active ulcerative colitis: A randomized, multicentre, open-label study by GETECCU.

Addition of pulse corticosteroids to oral prednisone in moderately active ulcerative colitis: A randomized, multicentre, open-label study by GETECCU.

Journal: Journal of Crohn's & colitis

Published: November 19, 2025

Assessing the beneficial effect of Lactobacillus plantarum MS1 and Lactobacillus delbrueckii YN1 on colitis in a rat model.

Assessing the beneficial effect of Lactobacillus plantarum MS1 and Lactobacillus delbrueckii YN1 on colitis in a rat model.

Journal: Iranian journal of microbiology

Published: November 14, 2025

Mesalazine-Induced Myocarditis in a 17-Year-Old: A Case Report.

Mesalazine-Induced Myocarditis in a 17-Year-Old: A Case Report.

Journal: Cureus

Published: November 13, 2025

Mesalamine for Colorectal Cancer Prevention Programme in Lynch syndrome (MesaCAPP): a multicentre, multinational, randomised, two-arm, double-blind, phase II clinical study with mesalamine or placebo in carriers with Lynch syndrome - a study protocol.

Mesalamine for Colorectal Cancer Prevention Programme in Lynch syndrome (MesaCAPP): a multicentre, multinational, randomised, two-arm, double-blind, phase II clinical study with mesalamine or placebo in carriers with Lynch syndrome - a study protocol.

Journal: BMJ open

Published: November 10, 2025

Impact of Oral Mesalamine on Clinical Remission and Mucosal Response in Mild to Moderate Ulcerative Colitis: A Prospective Observational Study.

Impact of Oral Mesalamine on Clinical Remission and Mucosal Response in Mild to Moderate Ulcerative Colitis: A Prospective Observational Study.

Journal: Cureus

Published: November 03, 2025

Showing 1-12 of 5,429

Last Updated: 02/24/2026